Related Experiment Video
Updated: Jul 21, 2026

Experimental Protocol to Investigate Particle Aerosolization of a Product Under Abrasion and Under Environmental Weathering
Published on: September 16, 2016
Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability
13M Pharmaceuticals, St. Paul, Minnesota 55144-1000, USA.
This study examines how the process of micronization affects the physical properties of albuterol sulfate. Micronization can introduce amorphous regions on the surface of the drug particles. These regions absorb more water and can convert back to a crystalline state depending on temperature and humidity. The researchers used several analytical techniques to detect these changes. They found that the physical state of the powder is dynamic and influenced by environmental factors. These findings suggest that proper storage conditions are important for maintaining the stability of micronized albuterol sulfate. The study highlights the need to understand how processing affects drug properties.
Area of Science:
- Pharmaceutical powder processing
- Crystallinity and amorphous phase analysis
- Drug stability and physical characterization
Background:
Understanding the physical state of pharmaceutical powders is essential for ensuring product stability and performance. Prior research has shown that milling processes can alter the crystalline structure of drug particles. These changes may introduce amorphous regions on the surface. Such regions are known to interact differently with environmental factors like humidity. The stability of these amorphous regions remains an open question in the field. No prior work had resolved the long-term behavior of micronized albuterol sulfate under varying conditions. This uncertainty drives the need for a detailed characterization of the material. The study aims to clarify how these structural changes affect the powder's physical properties. This gap motivated the current investigation into the effects of micronization on albuterol sulfate.
Purpose Of The Study:
This study focuses on the physical changes in albuterol sulfate caused by micronization. The goal is to determine how the process affects the powder's crystallinity and stability. The researchers aim to identify the extent of amorphous regions introduced by milling. They also seek to understand how these regions respond to environmental factors. The study addresses the lack of data on the dynamic behavior of micronized powders. The motivation comes from the need to ensure long-term stability in pharmaceutical products. The researchers use multiple analytical techniques to achieve this. Their approach allows for a comprehensive assessment of the material's properties.
Main Methods:
The study employs several analytical techniques to assess the physical properties of albuterol sulfate. Scanning electron microscopy is used to examine particle morphology. Differential scanning calorimetry measures thermal transitions. Powder x-ray diffraction evaluates crystallinity changes. Solution microcalorimetry detects interactions between the powder and water. Laser diffraction analyzes particle size distribution. Water vapor sorption analysis quantifies moisture uptake. The researchers compare micronized and unmicronized samples. These methods provide a detailed picture of the material's behavior.
Main Results:
Micronization introduces subtle changes in the crystallinity of albuterol sulfate. These changes are detected using multiple analytical techniques. Amorphous regions on the particle surface are observed after the process. These regions show a higher capacity for water sorption. The rate of amorphous to crystalline conversion is temperature-dependent. Relative humidity also influences the conversion kinetics. The material exhibits a dynamic physical state over time. These findings highlight the importance of environmental conditions in powder stability.
Conclusions:
The study confirms that micronization affects the crystallinity of albuterol sulfate. Amorphous regions on the surface are more prone to water absorption. The conversion between amorphous and crystalline phases is influenced by temperature and humidity. These findings suggest that the powder's physical state is not static. The researchers propose that environmental conditions play a key role in stability. The study supports the need for controlled storage conditions for micronized powders. The results emphasize the dynamic nature of the material. These conclusions align with the observed changes in crystallinity and moisture interactions.
Frequently Asked Questions
The study shows that micronization introduces amorphous regions on albuterol sulfate particles, which absorb more water and convert to crystalline phases under specific conditions.
The researchers used differential scanning calorimetry, powder x-ray diffraction, and solution microcalorimetry to detect subtle changes in crystallinity.
Relative humidity influences the rate of amorphous to crystalline conversion, showing that environmental conditions affect the powder's physical state.
Water vapor sorption analysis quantifies how much moisture the powder absorbs, which is linked to the presence of amorphous regions.
Temperature affects the kinetics of amorphous to crystalline conversion, indicating a dynamic physical state of the material.
The authors suggest that controlled storage conditions are necessary to maintain the stability of micronized albuterol sulfate.
Related Concept Videos
Recrystallization: Solid–Solution Equilibria
Crystal Growth: Principles of Crystallization
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent – the...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Drug Product Stability
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

